RxDoctor Payments Data

Alikemal Ozturk, MD

Neurological Surgery · Philadelphia, PANPI 1922275072

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,946 of the $95,374 with a category attached, or 71.2%. Medacta USA, Inc. accounts for 68.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $34,829 and has fallen 75.5% since, to $8,547 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,374in general payments, 2019–2025

Across 124 payments — averaging $769.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$65K
  • Medical Device Business Services, Inc.$16K
  • Synthes GmbH$5K
  • Globus Medical$4K
  • Innovasis Inc$4K
  • Johnson & Johnson$1K
  • plus $846 from 4 others

What the payments were for

  • Consulting fees$67,94671%
  • Speaking & faculty fees$1,5002%
  • Travel & lodging$21,29022%
  • Food & beverage$4,6385%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,374 in reported general payments places this provider in the 90th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$295,930
Medicare patients
235
Services billed
667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →